Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
KO CocaCola	$78.96 -1.8%	$77.75	$65.35 ▼ $82.66	$345.96B	0.35	13.11 million shs	32.46 million shs
O Realty Income	$61.31 -0.6%	$62.48	$55.52 ▼ $67.93	$57.53B	0.75	5.26 million shs	14.70 million shs
PFE Pfizer	$26.18 +0.2%	$26.77	$23.06 ▼ $28.75	$148.98B	0.35	33.36 million shs	48.26 million shs

Analysts Agree—These Gold Picks Outshine the Rest

Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
KO CocaCola	-1.86%	-3.19%	+0.15%	-3.07%	+10.99%
O Realty Income	-0.73%	-1.34%	-3.24%	-8.65%	+9.73%
PFE Pfizer	+0.11%	+1.02%	-0.32%	-5.16%	+12.96%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
KO CocaCola	$78.96 -1.8%	$77.75	$65.35 ▼ $82.66	$345.96B	0.35	13.11 million shs	32.46 million shs
O Realty Income	$61.31 -0.6%	$62.48	$55.52 ▼ $67.93	$57.53B	0.75	5.26 million shs	14.70 million shs
PFE Pfizer	$26.18 +0.2%	$26.77	$23.06 ▼ $28.75	$148.98B	0.35	33.36 million shs	48.26 million shs

Analysts Agree—These Gold Picks Outshine the Rest

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
KO CocaCola	-1.86%	-3.19%	+0.15%	-3.07%	+10.99%
O Realty Income	-0.73%	-1.34%	-3.24%	-8.65%	+9.73%
PFE Pfizer	+0.11%	+1.02%	-0.32%	-5.16%	+12.96%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
KO CocaCola	3.00	Buy	$86.80	9.93% Upside
O Realty Income	2.47	Hold	$67.35	9.85% Upside
PFE Pfizer	2.20	Hold	$28.82	10.08% Upside

Current Analyst Ratings Breakdown

Latest KO, O, and PFE Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/27/2026	PFE Pfizer	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral	$27.00
5/21/2026	KO CocaCola	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$85.00 ➝ $89.00
5/18/2026	KO CocaCola	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$90.00 ➝ $91.00
5/18/2026	KO CocaCola	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$87.00 ➝ $90.00
5/14/2026	PFE Pfizer	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Underperform	$26.00
5/13/2026	O Realty Income	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Neutral	$68.00 ➝ $66.00
5/12/2026	O Realty Income	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform
5/12/2026	O Realty Income	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Sector Outperform	$69.00 ➝ $72.00
5/11/2026	O Realty Income	Freedom Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
5/7/2026	O Realty Income	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$70.00 ➝ $71.00
5/6/2026	PFE Pfizer	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C-) ➝ Hold (C)

(Data available from 5/30/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
KO CocaCola	$47.94B	7.09	$3.20 per share	24.67	$8.31 per share	9.50
O Realty Income	$5.88B	9.72	$3.94 per share	15.55	$44.22 per share	1.39
PFE Pfizer	$62.58B	2.38	$4.40 per share	5.95	$15.86 per share	1.65

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
KO CocaCola	$13.11B	$3.18	24.83	22.62	3.21	27.80%	40.55%	12.90%	7/28/2026 (Estimated)
O Realty Income	$1.06B	$1.22	50.25	13.39	4.82	18.94%	2.80%	1.55%	8/5/2026 (Estimated)
PFE Pfizer	$7.77B	$1.31	19.99	9.15	N/A	11.83%	19.44%	8.41%	8/4/2026 (Estimated)

Latest KO, O, and PFE Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/6/2026	Q1 2026	O Realty Income	$1.10	$1.13	+$0.03	$0.33	$1.39 billion	$1.55 billion
5/5/2026	Q1 2026	PFE Pfizer	$0.7220	$0.75	+$0.0280	$0.47	$13.84 billion	$14.45 billion
4/28/2026	Q1 2026	KO CocaCola	$0.8120	$0.86	+$0.0480	$0.91	$12.24 billion	$12.47 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
KO CocaCola	$2.12	2.69%	+4.46%	66.67%	64 Years
O Realty Income	$3.24	5.29%	+4.50%	265.57%	1 Years
PFE Pfizer	$1.72	6.57%	-13.20%	131.30%	16 Years

Latest KO, O, and PFE Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
4/30/2026	KO CocaCola	quarterly	$0.53	2.69%	6/15/2026	6/15/2026	7/1/2026
5/14/2026	O Realty Income	monthly	$0.2705	5.29%	5/29/2026	5/29/2026	6/15/2026
4/22/2026	PFE Pfizer	quarterly	$0.43	6.71%	5/8/2026	5/8/2026	6/12/2026
4/14/2026	O Realty Income	monthly	$0.2705	5.05%	4/30/2026	4/30/2026	5/15/2026
3/11/2026	O Realty Income	monthly	$0.2705	5.31%	3/31/2026	3/31/2026	4/15/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
KO CocaCola	1.09	1.36	1.15
O Realty Income	0.72	1.56	1.56
PFE Pfizer	0.67	1.25	0.94

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
KO CocaCola	70.26%
O Realty Income	70.81%
PFE Pfizer	68.36%

Insider Ownership

Company	Insider Ownership
KO CocaCola	0.90%
O Realty Income	0.10%
PFE Pfizer	0.62%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
KO CocaCola	65,900	4.30 billion	4.26 billion	Optionable
O Realty Income	400	932.49 million	931.56 million	Optionable
PFE Pfizer	75,000	5.70 billion	5.66 billion	Optionable

KO, O, and PFE Headlines

Recent News About These Companies

Pfizer Pivots to Obesity and Oncology as Wall Street Waits

3 hours ago | tipranks.com

Mailbag: A Follow-Up on Pfizer & Other Questions

May 30 at 9:22 AM | etftrends.comE

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

May 30 at 8:38 AM | finance.yahoo.com

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

May 30 at 8:00 AM | businesswire.com

Pfizer Inc. $PFE Shares Bought by Triglav Investments D.O.O.

May 30 at 7:18 AM | marketbeat.com

Pfizer Inc. $PFE Shares Sold by Koss Olinger Consulting LLC

May 30 at 6:44 AM | marketbeat.com

Norges Bank Purchases New Position in Pfizer Inc. $PFE

May 30 at 6:44 AM | marketbeat.com

Pfizer Inc. $PFE Shares Sold by Forsta AP Fonden

May 30 at 4:31 AM | marketbeat.com

Fideuram Asset Management Ireland dac Takes $2.11 Million Position in Pfizer Inc. $PFE

May 30 at 4:08 AM | marketbeat.com

Amica Mutual Insurance Co. Has $5.05 Million Stake in Pfizer Inc. $PFE

May 30 at 3:23 AM | marketbeat.com

Pfizer's $10.5 Billion Oncology Bet Sends Innovent Shares Surging

May 29 at 7:11 PM | finance.yahoo.com

Arvinas to Present at Jefferies Global Healthcare Conference

May 29 at 7:11 PM | finance.yahoo.com

Insiders Aren’t Buying Pfizer Stock at $26 and That’s Actually a Good Thing

May 29 at 5:30 PM | finance.yahoo.com

Pfizer Expands Oncology Pipeline in $10.5B Innovent Deal

May 29 at 2:10 PM | finance.yahoo.com

Pfizer’s Real-World Lung Cancer Study on Dacomitinib: What Investors Should Know

May 29 at 12:50 PM | tipranks.com

Pfizer’s MET097 Obesity Trial Reaches Key Milestone: What Investors Should Watch Next

May 29 at 12:50 PM | tipranks.com

Pfizer’s VESPER-4 Obesity Trial Signals a Serious Push Into the GLP-1 Growth Market

May 29 at 12:50 PM | tipranks.com

Can AI crack pharma’s drug repurposing goldmine?

May 29 at 9:09 AM | pharmavoice.comP

Pfizer and Innovent Biologics sign $10.5bn cancer drug development deal

May 29 at 9:09 AM | pharmaceutical-technology.comP

Pfizer and Innovent Biologics sign $10.5B cancer drug deal

May 29 at 9:09 AM | qz.comQ

Seven-Year Analysis from Pfizer’s LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer

May 29 at 9:09 AM | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

KO, O, and PFE Company Descriptions

CocaCola NYSE:KO

$78.96 -1.45 (-1.81%)

Closing price 05/29/2026 03:59 PM Eastern

Extended Trading

$79.08 +0.12 (+0.15%)

As of 05/29/2026 07:59 PM Eastern

The Coca-Cola Company, a beverage company, manufactures, markets, and sells various nonalcoholic beverages worldwide. The company provides sparkling soft drinks, sparkling flavors; water, sports, coffee, and tea; juice, value-added dairy, and plant-based beverages; and other beverages. It also offers beverage concentrates and syrups, as well as fountain syrups to fountain retailers, such as restaurants and convenience stores. The company sells its products under the Coca-Cola, Diet Coke/Coca-Cola Light, Coca-Cola Zero Sugar, caffeine free Diet Coke, Cherry Coke, Fanta Orange, Fanta Zero Orange, Fanta Zero Sugar, Fanta Apple, Sprite, Sprite Zero Sugar, Simply Orange, Simply Apple, Simply Grapefruit, Fresca, Schweppes, Thums Up, Aquarius, Ayataka, BODYARMOR, Ciel, Costa, Dasani, dogadan, FUZE TEA, Georgia, glacéau smartwater, glacéau vitaminwater, Gold Peak, Ice Dew, I LOHAS, Powerade, Topo Chico, AdeS, Del Valle, fairlife, innocent, Minute Maid, and Minute Maid Pulpy brands. It operates through a network of independent bottling partners, distributors, wholesalers, and retailers, as well as through bottling and distribution operators. The company was founded in 1886 and is headquartered in Atlanta, Georgia.

Realty Income NYSE:O

$61.30 -0.39 (-0.62%)

Closing price 05/29/2026 03:59 PM Eastern

Extended Trading

$61.33 +0.02 (+0.04%)

As of 05/29/2026 07:56 PM Eastern

Realty Income, The Monthly Dividend Company, is an S&P 500 company and member of the S&P 500 Dividend Aristocrats index. We invest in people and places to deliver dependable monthly dividends that increase over time. The company is structured as a real estate investment trust ("REIT"), and its monthly dividends are supported by the cash flow from over 15,450 real estate properties (including properties acquired in the Spirit merger in January 2024) primarily owned under long-term net lease agreements with commercial clients. To date, the company has declared 644 consecutive monthly dividends on its shares of common stock throughout its 55-year operating history and increased the dividend 123 times since Realty Income's public listing in 1994 (NYSE: O).

Pfizer NYSE:PFE

$26.18 +0.04 (+0.16%)

Closing price 05/29/2026 03:59 PM Eastern

Extended Trading

$26.15 -0.03 (-0.13%)

As of 05/29/2026 07:59 PM Eastern

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest KO, O, and PFE Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest KO, O, and PFE Earnings

Compare Dividends

Latest KO, O, and PFE Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

KO, O, and PFE Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

KO, O, and PFE Company Descriptions

CocaCola NYSE:KO

Realty Income NYSE:O

Pfizer NYSE:PFE

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest KO, O, and PFE Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest KO, O, and PFE Earnings

Compare Dividends

Latest KO, O, and PFE Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

KO, O, and PFE Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

KO, O, and PFE Company Descriptions

CocaCola NYSE:KO

Realty Income NYSE:O

Pfizer NYSE:PFE

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools